SCHEMBL8308337

SCHEMBL8308337

CC(C)(C)OC(=O)NC1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(Cl)cc4)n3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.51
PIK3CA P42336 2/20 0.47
PIK3CB P42338 2/20 0.47
PIK3CG P48736 2/20 0.47
IKBKB O14920 10/20 0.46
CHUK O15111 8/20 0.46
IKBKG Q9Y6K9 7/20 0.46
CDK1 P06493 2/20 0.46
CDK2 P24941 2/20 0.46
AKT1 P31749 1/20 0.46
CCNT1 O60563 1/20 0.46
CCNA2 P20248 1/20 0.46
CDK9 P50750 1/20 0.46
CCNA1 P78396 1/20 0.46
NOS3 P29474 1/20 0.45
NOS1 P29475 1/20 0.45
NOS2 P35228 1/20 0.45
CFTR P13569 1/20 0.45
MEN1 O00255 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4074601 0.88 IKBKB (0.50) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL14021077 0.86 CDK2 (0.58) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL14063766 0.85 IKBKB (0.51) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL8316042 0.85 IKBKB (0.49) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL8312581 0.85 CDK1 (0.58) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL13590857 0.84 CDK1 (0.54) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL11924743 0.84 GRM5 (0.60) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL11924740 0.84 MTOR (0.51) PIK3CAPIK3CBPIK3CGIKBKBCHUK
Hydrochloric Acid SCHEMBL4071661 0.84 CDK1 (0.53) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL8254568 0.83 JAK2 (0.55) PIK3CAPIK3CBPIK3CGIKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1349840-B1 ANILINOPYRIMIDINE DERIVATIVES AS JNK PATHWAY INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO SIGNAL PHARM LLC (US) 2009-03-11 EP disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed